Detalles de la búsqueda
1.
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study.
Hepatology
; 74(1): 19-27, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811356
2.
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir.
J Hepatol
; 75(4): 820-828, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023351
3.
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061289
4.
Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29180522
5.
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29084747
6.
Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir.
J Med Virol
; 90(1): 109-119, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28842997
7.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30600291
8.
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193664
9.
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir.
Antimicrob Agents Chemother
; 60(2): 1106-13, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26643326
10.
Exploratory study of oral combination antiviral therapy for hepatitis C.
N Engl J Med
; 368(1): 45-53, 2013 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23281975
11.
Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.
Antimicrob Agents Chemother
; 59(11): 6807-15, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26282418
12.
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir.
Antimicrob Agents Chemother
; 59(9): 5445-54, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26100711
13.
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.
Antimicrob Agents Chemother
; 59(2): 988-97, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25451053
14.
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
JAMA
; 313(12): 1223-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25706092
15.
Occupational Stress Among Middle-Aged Professionals in India.
Ann Neurosci
; 31(2): 95-104, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38694715
16.
Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences.
Genome Med
; 16(1): 43, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515211
17.
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1.
J Hepatol
; 59(1): 18-23, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23439262
18.
Prevalence of psychiatric morbidity amongst the community dwelling rural older adults in northern India.
Indian J Med Res
; 138(4): 504-14, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24434257
19.
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19.
Pharmacol Res Perspect
; 11(1): e01036, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537346
20.
Mental health promotion for elderly populations in World Health Organization South-East Asia Region: Needs and resource gaps.
World J Psychiatry
; 12(1): 117-127, 2022 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35111583